{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:04:43Z","timestamp":1789941883812,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T00:00:00Z","timestamp":1400803200000},"content-version":"vor","delay-in-days":356,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.oooo.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T17:31:41Z","timestamp":1365269501000},"page":"e32-e36","source":"Crossref","is-referenced-by-count":72,"title":["Osteonecrosis of the mandible associated with bevacizumab therapy"],"prefix":"10.1016","volume":"115","author":[{"given":"Alan Roger","family":"Santos-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano Augusto","family":"Beliz\u00e1rio Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto de","family":"Castro J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo Brito","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Prado Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Bianca","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2013.02.001_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.oraloncology.2011.03.028","article-title":"Oral complications of targeted cancer therapies: a narrative literature review","volume":"47","author":"Watters","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2013.02.001_bib2","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1200\/JCO.2007.12.3026","article-title":"Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non\u2013small-cell lung cancer","volume":"25","author":"Herbst","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2013.02.001_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1634\/theoncologist.2009-0155","article-title":"Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials","volume":"15","author":"Geiger-Gritsch","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.oooo.2013.02.001_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002512-200926040-00002","article-title":"Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?","volume":"26","author":"Ziemssen","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.oooo.2013.02.001_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1634\/theoncologist.11-1-85","article-title":"Bevacizumab-induced nasal septum perforation","volume":"11","author":"Fakih","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.oooo.2013.02.001_bib6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1634\/theoncologist.11-10-1070","article-title":"Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer","volume":"11","author":"Traina","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.oooo.2013.02.001_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-010-0933-9","article-title":"Osteonecrosis of the jaw and bevacizumab therapy","volume":"122","author":"Van Poznak","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.oooo.2013.02.001_bib8","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"20","author":"Estilo","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2013.02.001_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/annonc\/mdn653","article-title":"Bevacizumab-associated osteonecrosis of the jaw","volume":"19","author":"Greuter","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oooo.2013.02.001_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039463200902200429","article-title":"Bevacizumab-related osteonecrosis of the jaw","volume":"22","author":"Serra","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.oooo.2013.02.001_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and anti-angiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.oooo.2013.02.001_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.oooo.2013.02.001_bib13","first-page":"410","article-title":"Bevacizumab (avastin): an anti-angiogenic drug associated with osteonecrosis of the jaw","volume":"59","author":"Wynn","year":"2011","journal-title":"Gen Dent"},{"key":"10.1016\/j.oooo.2013.02.001_bib14","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.oraloncology.2011.07.030","article-title":"A\u00a0case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit","volume":"48","author":"Di\u015fel","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2013.02.001_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","article-title":"Osteonecrosis after administration of intravitreous bevacizumab","volume":"70","author":"Hopp","year":"2012","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2013.02.001_bib16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","article-title":"Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies","volume":"28","author":"Shih","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.oooo.2013.02.001_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: bisphosphonates and osteonecrosis of the jaw","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oooo.2013.02.001_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clbc.2011.02.001","article-title":"Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with\/without bevacizumab","volume":"11","author":"Ngamphaiboon","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.oooo.2013.02.001_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.14219\/jada.archive.2011.0220","article-title":"Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab","volume":"142","author":"Francini","year":"2011","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.oooo.2013.02.001_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.arbres.2012.01.007","article-title":"Osteonecrosis of the jaw in a patient with advanced non-small-cell lung cancer receiving bevacizumab","volume":"48","author":"Katsenos","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.oooo.2013.02.001_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"Am Dent Assoc"},{"key":"10.1016\/j.oooo.2013.02.001_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","article-title":"Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases","volume":"110","author":"Hoefert","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2013.02.001_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:54:12Z","timestamp":1539748452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440313000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S2212440313000539"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2013.02.001","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}